Keren Pharmaceutical entered the industry of Commercial Biotechnical Research in 2004 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541711, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.
To acquire more information, please contact David Dreyfus by calling No number given during business hours. You can also write to the business’ Single Location at 488 Norton Parkway, New Haven, Connecticut CT 06511. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Keren Pharmaceutical |
| Representative: | David Dreyfus |
| Place of Business: | 488 Norton Parkway, New Haven, CT 06511 |
| Contact Number: | No number given |
| Type of Service: | Commercial Biotechnical Research |
| SIC Number: | 8731 |
| NAICS Number: | 541711 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2004 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Keren Pharmaceutical is a company operating from New Haven, Connecticut providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 2004 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 541711 as Commercial Biotechnical Research.
With a current employee count of 1 to 4, Keren Pharmaceutical has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative David Dreyfus at No number given for related queries, or to locate its Single Location using the coordinates 41.324501,-72.942448.
The Single Location can also be found at the street address 488 Norton Parkway in New Haven, Connecticut 06511 and can be engaged online through the company website at , the company Twitter , and Facebook page .